Skip to content

Clinical trials

Terminated Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Status: Terminated Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20091
20101
20122
20141
20153
20162
20172
20187
20194
20205
20212
20223
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
Pfizer2
University of Washington2
Alentis Therapeutics AG1
Amgen1
Daiichi Sankyo1
Dana-Farber Cancer Institute1
Dynavax Technologies Corporation1
Evopoint Biosciences Inc.1
Formation Biologics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck40
Carcinoma, Non-Small-Cell Lung16
Triple Negative Breast Neoplasms12
Melanoma11
Neoplasm Metastasis8
Head and Neck Neoplasms7
Carcinoma, Transitional Cell6
Colorectal Neoplasms6
Stomach Neoplasms6
Carcinoma, Renal Cell5

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.